Temporal evaluation of CYP mRNA in mice administered with prototypical P450 inducers: comparison with conventional

Er-Jia Wang1, George Mandakas, Jairam Palamanda

  • 1Department of Genetic and Molecular Toxicology, Schering-Plough Corporation, Summit, New Jersey 07901, USA. erjia.wang@spcorp.com

Insights

Monitoring cytochrome P450 (CYP) induction via mRNA in mice is reliable for enzyme activity assessment, especially after two days of chemical treatment. This approach provides a useful tool for evaluating CYP enzyme induction in preclinical studies.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Toxicology

Background:

  • Assessing cytochrome P450 (CYP) induction at the mRNA level in preclinical rodent models is increasingly important.
  • Concerns persist regarding the correlation between mRNA levels and actual enzyme activity, particularly in mice.

Purpose of the Study:

  • To systematically evaluate temporal changes in CYP 1a1, 1a2, 2b10, 3a11, and 4a10 at mRNA, protein, and activity levels.
  • To determine the extent to which mRNA levels can quantitatively or qualitatively assess CYP enzyme induction in mice.

Main Methods:

  • Male CD-1 mice were administered daily doses of beta-naphthoflavone, phenobarbital, dexamethasone, clofibrate, or control vehicles.
  • Livers were collected at 0.5, 1, 2, 4, and 8 days post-treatment for RNA and microsomal analysis.

Main Results:

  • A good correlation was observed between mRNA, protein, and enzyme activity levels for the studied CYPs.
  • The strongest correlation was found at time points between Days 2 and 8 of daily dosing.
  • These findings suggest that monitoring CYP mRNA is most accurate beyond Day 2 of chemical treatment.

Conclusions:

  • The mRNA approach is a valuable tool for monitoring CYP induction in mice.
  • This method is particularly effective when the duration of chemical treatment exceeds two days.
  • The study supports the use of mRNA analysis for reliable assessment of CYP enzyme induction in preclinical settings.